Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Harvard Business School
McKinsey
Baxter
Medtronic

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. Alvogen Pine Brook, LLC (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Purdue Pharma L.P. v. Alvogen Pine Brook, LLC (D. Del. 2017)

Docket   Start Trial Date Filed 2017-08-11
Court District Court, D. Delaware Date Terminated 2018-04-24
Cause 35:0145 Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ACTAVIS LABORATORIES FL, INC.; ALVOGEN PINE BROOK, LLC; GRUNENTHAL GMBH; PURDUE PHARMA L.P.
Patents 6,733,783; 8,309,060; 8,361,499; 8,529,948; 8,551,520; 8,647,667; 8,808,740; 9,023,401; 9,056,052; 9,060,940; 9,084,816; 9,095,614; 9,095,615; 9,198,863; 9,205,056; 9,289,391; 9,486,412; 9,486,413; 9,492,389; 9,492,390; 9,492,391; 9,517,236; 9,545,380; 9,572,779; 9,572,804; 9,669,023; 9,669,024; 9,675,610; 9,675,611; 9,682,077
Attorneys Dominick T. Gattuso; Gita Srivastava; Jack B. Blumenfeld; Jeffrey I.D. Lewis; Megan Elizabeth Dellinger; Michelle Wang; Rodger Dallery Smith , II
Firms Heyman Enerio Gattuso & Hirzel LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Purdue Pharma L.P. v. Alvogen Pine Brook, LLC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Purdue Pharma L.P. v. Alvogen Pine Brook, LLC (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-08-11 1 687-GMS, for patent infringement of United States Patents Nos. 6,733,783 (“the ‘783 patent”); 8,361,499…, for patent infringement of the ‘783 patent, the ‘499 patent, the ‘520 patent, the ‘667 patent, the …for patent infringement of the ‘052 patent; the ‘940 patent; the ‘816 patent; and the ‘614 patent based…alleging that the ‘023 patent, ‘024 patent, ‘610 patent, ‘611 patent, and ‘077 patent listed in the FDA’s…of each of the ‘023 patent, ‘024 patent, ‘611 patent, ‘077 patent, and ‘610 patent, and that the commercial External link to document
2018-04-24 22 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,669,023 ;9,669,024 ;9,675,610…2017 24 April 2018 1:17-cv-01131 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
2017-08-11 5 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,669,023; 9,669,024; 9,675,610…2017 24 April 2018 1:17-cv-01131 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKesson
Merck
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.